Protease Profile of Tumor-Associated Mast Cells in Melanoma
Carboxypeptidasen, Carboxypeptidases, Chymase, Mast cells, Mastzellen, Melanom, Melanoma, Tryptase
Atiakshin D, et al. Protease Profile of Tumor-Associated Mast Cells in Melanoma. Int J Mol Sci 2022 Aug 11;23(16):8930. doi:10.3390/ijms23168930
Pentafluorophosphato-Phenylalanines: Amphiphilic Phosphotyrosine Mimetics Displaying Fluorine-Specific Protein Interactions
Chemical Biology, Chemische Biologie, Drug Development, Medikamentenentwicklung, Pentafluorophosphate, Pentafluorophosphates, Phosphotyrosin Biomimetica, Phosphotyrosine Biomimetics, Protein Tyrosin Phosphatasen, Protein Tyrosine Phosphatases
Accorsi M, et al. Pentafluorophosphato-Phenylalanines: Amphiphilic Phosphotyrosine Mimetics Displaying Fluorine-Specific Protein Interactions. Angew Chem Int Ed Engl 2022 Jun 20;61(25):e202203579. doi:10.1002/anie.202203579
Outcome of Ordinary Polymorphous Adenocarcinomas of the Salivary Glands in Comparison With Papillary and Cribriform Subtypes
adenocarcinoma, molecular pathology
Clausen S, Falk M, Oesterling F, Fehr A, Stang A, Boecker W, et al. Outcome of Ordinary Polymorphous Adenocarcinomas of the Salivary Glands in Comparison With Papillary and Cribriform Subtypes. Anticancer Res 2022 Mar;42(3):1455-1463. doi 10.21873/anticanres.15616
Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells
Carboxypeptidase A3, Granula, granules, Mast cells, Mastzellen, secretome, secretory pathways, Sekretom, Sekretorische Signalwege, Specific tissue microenvironment, spezifisches Gewebemikromilieu
Atiakshin D, et al. Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells. Cells 2022 Feb 6;11(3):570. doi:10.3390/cells11030570
TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy- EGFR mutated non-small cell lung cancer IV patients treated with osimertinib
EGFR, metastasiert, metastatic, non small cell lung cancer (NSCLC), NSCLC, Osimertinib, TP53 co-mutation, TP53 Komutation
Roeper J, et al. TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy- EGFR mutated non-small cell lung cancer IV patients treated with osimertinib. Transl Lung Cancer Res 2022 Jan;11(1):4-13. doi:10.21037/tlcr-21-754
Atrial Giant Cell Myocarditis as a Cause of Heart Failure: Diagnostic Pathway and Successful Treatment
Paitazoglou C, Bergmann MW, Tiemann K, et al. Atrial Giant Cell Myocarditis as a Cause of Heart Failure: Diagnostic Pathway and Successful Treatment. JACC Case Rep. 2022 Jan 5;4(1):66-71. doi:10.1016/j.jaccas.2021.11.007
Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective
Malapelle U, Tiseo M, Vivancos A, Kapp J, Serrano MJ, Tiemann M. Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective. J. Mol. Pathol. 2021 Aug 18;2(3):255-273. doi:10.3390/jmp2030022
Morbus Castleman – ein seltenes, heterogenes Krankheitsbild
Hoffmann C, Tepel J, Tiemann M. Morbus Castleman – ein seltenes, heterogenes Krankheitsbild. Best Practice Onkologie 2021 Mar 09;16:198-206. doi:10.1007/s11654-021-00300-4
Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping
CRTC1-MAML2, Gene fusion, Genfusion, Head and neck neoplasms, Kopf-Hals Tumore, Mucoepidermoid carcinoma, Mukoepidermoidkarzinom, Neoplasm grading, Observer variation, Observer-Variabilität
Fehr A, et al. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping. Virchows Arch 2021 Nov;479(5):975-985. doi:10.1007/s00428-021-03146-x
MSI testing : What’s new? What should be considered?
DNA mismatch repair, Endometrial carcinoma, Endometriumkarzinom, Immun-Checkpoint-Inhibition, Immune checkpoint inhibitors, Microsatellite instability, Mikrosatelliten-Instabilität, Prognose, Prognosis